---
title: "ASBPW.US (ASBPW.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ASBPW.US/news.md"
symbol: "ASBPW.US"
name: "ASBPW.US"
parent: "https://longbridge.com/en/quote/ASBPW.US.md"
datetime: "2026-03-03T23:54:48.136Z"
locales:
  - [en](https://longbridge.com/en/quote/ASBPW.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ASBPW.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ASBPW.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/ASBPW.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/ASBPW.US/news.md)


# ASBPW.US (ASBPW.US) — Related News

### [Chronic kidney disease market set to grow (2025-2034) due to increased demand for early diagnosis and treatments, driven by diabetes, hypertension, and aging populations.](https://longbridge.com/en/news/277690069.md)
*2026-03-03T22:32:20.000Z*
> The ongoing expansion of the chronic kidney disease market is fueled by the increasing occurrence of diabetes and hypert

### [The semiconductor ETF fell nearly 3.8%, leading the decline among U.S. sector ETFs](https://longbridge.com/en/news/277677793.md)
*2026-03-03T21:06:46.000Z*
> On Tuesday (March 3), the semiconductor ETF fell by 3.77%, the global technology stock index ETF and biotechnology index

### [14:36 ETHematologic Malignancies Market to Reach USD 128.48 Billion by 2032, Driven by Immunotherapy, CAR-T, and Precision Oncology - Credence Research Inc.](https://longbridge.com/en/news/277670197.md)
*2026-03-03T19:39:08.000Z*
> The Hematologic Malignancies Market is projected to grow from USD 72.2 billion in 2024 to USD 128.5 billion by 2032, wit

### [China establishes an international "universal language" for stem cells](https://longbridge.com/en/news/277604686.md)
*2026-03-03T10:33:51.000Z*
> The international standard led by our country—the core characteristics of stem cell data—has been officially released, b

### [The Battle for Weight Loss Drugs in China: Price Cuts, Gamesmanship, and Return](https://longbridge.com/en/news/277561697.md)
*2026-03-03T04:31:36.000Z*
> The weight loss drug market in China is experiencing fierce competition, primarily dominated by Novo Nordisk's semagluti

### [GLP-1 drugs tied to fewer ER visits and decreased use of migraine drugs in people with chronic migraine.](https://longbridge.com/en/news/277498778.md)
*2026-03-02T16:32:18.000Z*
> A recent study suggests that starting GLP-1 drugs for conditions such as diabetes might lead to a decrease in emergency 

### [ASPIRE BIOPHARMA HOLDINGS INC C/WTS 14/02/2030 (TO PUR COM) | 10-Q: FY2025 Q3 Revenue: USD 1.941 K](https://longbridge.com/en/news/265940155.md)
*2025-11-14T13:24:16.000Z*
### [ASPIRE BIOPHARMA HOLDINGS INC C/WTS 14/02/2030 (TO PUR COM) | 10-Q: FY2025 Q2 EPS: USD -0.41](https://longbridge.com/en/news/252920371.md)
*2025-08-13T21:04:18.000Z*
### [ASPIRE BIOPHARMA HOLDINGS INC C/WTS 14/02/2030 (TO PUR COM) | 10-Q: FY2025 Q1 EPS: USD -0.42](https://longbridge.com/en/news/240234862.md)
*2025-05-14T20:47:10.000Z*